T. Jeroen N. Hiltermann, MD, discusses findings from phase 1/2 ARTEMIDE-01 trial.
T. Jeroen N. Hiltermann, MD
Advertisement
Articles by T. Jeroen N. Hiltermann, MD
Advertisement
Latest Updated Articles
Dr Hiltermann on ARTEMIDE-01 Data With Rilvegostomig in Metastatic NSCLCSeptember 11th 2024
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC
3
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
4
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
5